Compugen (Compugen) Price-to-Tangible-Book : 2.61 (As of Apr. 29, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Compugen Price-to-Tangible-Book?

As of today (2024-04-29), Compugen's share price is $1.92. Compugen's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.74. Hence, Compugen's Price to Tangible Book Ratio of today is 2.61.

The historical rank and industry rank for Compugen's Price-to-Tangible-Book or its related term are showing as below:

CGEN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.7 Med: 3.81 Max: 9.65
Current: 2.7

During the past 13 years, Compugen's highest Price to Tangible Book Ratio was 9.65. The lowest was 0.70. And the median was 3.81.

CGEN's Price-to-Tangible-Book is ranked worse than
50.33% of 1220 companies
in the Biotechnology industry
Industry Median: 2.65 vs CGEN: 2.70

A closely related ratio is called PB Ratio. As of today, Compugen's share price is $1.92. Compugen's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.74. Hence, Compugen's P/B Ratio of today is 2.61.

Compugen Price-to-Tangible-Book Historical Data

The historical data trend for Compugen's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compugen Price-to-Tangible-Book Chart

Compugen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

10.57

8.46

3.48

0.80

2.69

Compugen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.80	0.88	1.62	1.54	2.69

Competitive Comparison of Compugen's Price-to-Tangible-Book

For the Biotechnology subindustry, Compugen's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compugen's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Compugen's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Compugen's Price-to-Tangible-Book falls into.

Compugen Price-to-Tangible-Book Calculation

Compugen's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.92	/	0.735
	=	2.61

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Compugen Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Compugen's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Compugen (Compugen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Compugen Ltd (NAS:CGEN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

CGEN:Israel

Address

26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849

Website

https://www.cgen.com

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.